The MRC Prize Committee also recognised Prof Tabrizi’s ‘dedication to promoting a positive, open and fair research culture and actively championing equality, diversity and inclusion (EDI)’, for decades at UCL, including being chosen as a UCL academic role model in 2013, and by being an active champion and mentor of women in science.
Prof Tabrizi is Director of the UCL Huntington’s Disease (HD) Centre, Professor of Clinical Neurology and joint head of Department of Neurodegenerative Disease at the UCL Queen Square Institute of Neurology and a Group Leader at the UK DRI.
Prof Sarah Tabrizi said:
"I am incredibly honoured to receive the MRC Millennium Medal for 2022 as a joint winner; it is a recognition of all the patients and families with Huntington's disease whom I have worked with over the last 25 years.
I am also grateful to all my PhD students, postdocs, clinical fellows, past and present, and colleagues in the UCL HD centre, without their partnership I wouldn't be where I am today, and to my colleagues at the UCL Queen Square Institute of Neurology and the UK Dementia Research Institute for their immense support over the years - my success is also dependent on all of them."
Prof Bart De Strooper, Director of the UK DRI, said:
“I am thrilled that the MRC has awarded Prof Tabrizi the Millennium Medal. She is an outstanding scientist, producing world class research. Her focus and drive to find a cure for Huntington’s disease, together with her enthusiasm and leadership, is truly inspiring. We are extremely fortunate to have her as part of the UK DRI, and this achievement is richly deserved.”
Recognising outstanding science
Prof John Iredale, MRC Executive Chair said:
“These MRC prizes pay tribute to some of the extraordinary impacts that science carried out by our research community in the UK and abroad have delivered for us all.
“It is especially pleasing that the MRC has been able to recognise the world class work of the two outstanding scientists receiving our MRC Millennium Medal. The impact of their work is not only via the world-class science they have undertaken but also in their championing of open and inclusive research environments that can only make UK science and research more successful.
“The breadth of impact achieved by the finalists in our first MRC Impact Prize competition is also hugely impressive and humbling. We are proud to be recognising scientific teams and individuals making a global difference to advance medical research.”
Read the full story on the MRC website. To find out more about Prof Sarah Tabrizi's work, visit her UK DRI profile or read our new feature “I'm not going to give up”: in conversation with 2022 MRC Millennium Medal winner Prof Sarah Tabrizi
Article published: 8 December 2022
Banner image: Shutterstock/Kateryna Kon